Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
<strong>Study question:</strong> How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? <strong>Methods:</strong> In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were...
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2015
|